Search - tctmd.com

Displaying 181 - 200 of 243

Sort: Relevancy | Date

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

News Conference News EHRA 2019

Tentative Link Found Between Solar Storms, New-Onset A-fib

Todd Neale

March 20, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Featured Fellow

Marinos Charalambous, MD

Yael L. Maxwell

January 09, 2019

News Daily News

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

L.A. McKeown

December 21, 2018

News Daily News

Hospitals With Higher SAVR Mortality Likely to Have Higher TAVR Mortality, Too

L.A. McKeown

December 12, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Daily News

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Yael L. Maxwell

October 19, 2018

News Daily News

PARAMEDIC2: Epinephrine in Cardiac Arrest Is Good for Survival, Bad for the Brain

Shelley Wood

July 19, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Daily News

Left or Right? Transradial PCI Outcomes Generally Similar Regardless of Side Chosen

Yael L. Maxwell

May 21, 2018

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Daily News

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Caitlin E. Cox

May 09, 2018

News Daily News

Spending More Won’t Necessarily Improve Acute MI Outcomes

Todd Neale

December 22, 2017

News Industry News

Baim Institute Names Dr. C. Michael Gibson As CEO

December 05, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

Advertisement

Time and Money: PCI Public Reporting Requirements Take Their Toll

Tentative Link Found Between Solar Storms, New-Onset A-fib

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Marinos Charalambous, MD

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

Hospitals With Higher SAVR Mortality Likely to Have Higher TAVR Mortality, Too

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

PARAMEDIC2: Epinephrine in Cardiac Arrest Is Good for Survival, Bad for the Brain

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Left or Right? Transradial PCI Outcomes Generally Similar Regardless of Side Chosen

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

Spending More Won’t Necessarily Improve Acute MI Outcomes

Baim Institute Names Dr. C. Michael Gibson As CEO

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content